Reuters -- U.S. drug reviewers found a Novartis AG drug effective for preventing rejection of transplanted kidneys but they raised safety issues ahead of an advisory panel review, documents released on Thursday showed.
Reuters -- U.S. drug reviewers found a Novartis AG drug effective for preventing rejection of transplanted kidneys but they raised safety issues ahead of an advisory panel review, documents released on Thursday showed.
